Circulating Tumor DNA as a Marker for Treatment Response in Metastatic Melanoma Patients Using Next-Generation Sequencing—A Prospective Feasibility StudyB.M. Berger, Ariane Aigelsreiter, Doritt Franz et al.|Cancers|2021Cited by 4